SAGE Therapeutics's total assets for Q1 2025 were $469.67M, a decrease of -14.17% from the previous quarter. SAGE total liabilities were $59.82M for the fiscal quarter, a -27.17% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.